Trial intelligence / Profile preview

Glutamic Acid for Vincristine Toxicity in Children

NCT00369564Phase 3Completed

Sponsor
University of South Florida
Start
May 2007
Primary completion
Nov 2012
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Glutamic acid in neurotoxicity, peripheral neuropathy, sponsored by University of South Florida. Started May 2007; status: completed.

02

Drugs

Glutamic acid
03

Conditions

neurotoxicityperipheral neuropathy

Beyond the preview

Go deeper on NCT00369564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00369564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call